(Circulation. 2000;102:1139.)
© 2000 American Heart Association, Inc.
Clinical Investigation and Reports |
From the Hypertension and Cardiovascular Rehabilitation Unit (R.H.F., J.A.S., L.T., J.G.), Catholic University of Leuven, Leuven, Belgium; Imperial College (C.J.B.), Hammersmith Hospital, London, UK; Department of Cardiology (D.C.), University of Gent, Gent, Belgium; Department of Internal Medicine (P.W.d.L.), University of Maastricht, Maastricht, the Netherlands; Hypertension Division (J.D.), University Medical Center, Ljubljana, Slovenia; Department of Epidemiology and Health Promotion (M.J.), National Public Health Institute, Helsinki, Finland; Istituto Auxologico Italiano (G.L., G.P.), Ospedale San Luca, Milano, Italy; Beaumont Hospital (E.O.), Dublin, Ireland; Clinica Medica IV (P.P.), Universitá di Padova, Padova, Italy; Hospital "12de Octubre" (J.L.R.), Madrid, Spain; Department of Medicine (H.V.), Helsinki University Central Hospital, Helsinki, Finland; and Department of Medicine and Therapeutics (J.W.), University of Aberdeen, Aberdeen, UK.
Correspondence to R. Fagard, MD, PhD, Department of Medicine, U.Z. GasthuisbergHypertensie, Herestraat 49 B-3000, Leuven, Belgium. E-mail robert.fagard{at}uz.kuleuven.ac.be
BackgroundThe goal of the present study was to assess the effect of antihypertensive therapy on clinic (CBP) and ambulatory (ABP) blood pressures, on ECG voltages, and on the incidence of stroke and cardiovascular events in older patients with sustained and nonsustained systolic hypertension.
Methods and ResultsPatients who were
60 years old, with
systolic CBP of 160 to 219 mm Hg and
diastolic CBP of <95 mm Hg, were randomized into the
double-blind placebo-controlled Systolic Hypertension in Europe
(Syst-Eur) Trial. Treatment consisted of nitrendipine, with the
possible addition of enalapril, hydrochlorothiazide, or
both. Patients enrolled in the Ambulatory Blood Pressure Monitoring
Side Project were classified according to daytime systolic
ABP into 1 of 3 subgroups: nonsustained hypertension (<140
mm Hg), mild sustained hypertension (140 to 159 mm Hg), and
moderate sustained hypertension (
160 mm Hg). At baseline,
patients with nonsustained hypertension had smaller ECG voltages
(P<0.001) and, during follow-up, a lower incidence of
stroke (P<0.05) and of cardiovascular
complications (P=0.01) than other groups. Active
treatment reduced ABP and CBP in patients with sustained hypertension
but only CBP in patients with nonsustained hypertension
(P<0.001). The influence of active treatment on ECG
voltages (P<0.05) and on the incidence of stroke
(P<0.05) and cardiovascular events
(P=0.06) was more favorable than that of placebo only in
patients with moderate sustained hypertension.
ConclusionsPatients with sustained hypertension had higher ECG voltages and rates of cardiovascular complications than did patients with nonsustained hypertension. The favorable effects of active treatment on these outcomes were only statistically significant in patients with moderate sustained hypertension.
Key Words: blood pressure monitoring aging hypertrophy, left ventricular prognosis hypertension, white coat trials
This article has been cited by other articles:
![]() |
R. H. Fagard, H. Celis, L. Thijs, J. A. Staessen, D. L. Clement, M. L. De Buyzere, and D. A. De Bacquer Daytime and Nighttime Blood Pressure as Predictors of Death and Cause-Specific Cardiovascular Events in Hypertension Hypertension, January 1, 2008; 51(1): 55 - 61. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Minutolo, S. Borrelli, R. Scigliano, V. Bellizzi, P. Chiodini, B. Cianciaruso, F. Nappi, P. Zamboli, G. Conte, and L. De Nicola Prevalence and clinical correlates of white coat hypertension in chronic kidney disease Nephrol. Dial. Transplant., August 1, 2007; 22(8): 2217 - 2223. [Abstract] [Full Text] [PDF] |
||||
![]() |
Authors/Task Force Members:, G. Mancia, G. De Backer, A. Dominiczak, R. Cifkova, R. Fagard, G. Germano, G. Grassi, A. M. Heagerty, S. E. Kjeldsen, et al. 2007 Guidelines for the Management of Arterial Hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC) Eur. Heart J., June 11, 2007; (2007) ehm236v1. [Full Text] [PDF] |
||||
![]() |
M. Kikuya, T. W. Hansen, L. Thijs, K. Bjorklund-Bodegard, T. Kuznetsova, T. Ohkubo, T. Richart, C. Torp-Pedersen, L. Lind, H. Ibsen, et al. Diagnostic Thresholds for Ambulatory Blood Pressure Monitoring Based on 10-Year Cardiovascular Risk Circulation, April 24, 2007; 115(16): 2145 - 2152. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. G. Pickering, D. Shimbo, and D. Haas Ambulatory blood-pressure monitoring. N. Engl. J. Med., June 1, 2006; 354(22): 2368 - 2374. [Full Text] [PDF] |
||||
![]() |
F. H. Messerli and D. Cotiga Masked Hypertension and White-Coat Hypertension: Therapeutic Navigation Between Scylla and Charybdis J. Am. Coll. Cardiol., August 2, 2005; 46(3): 516 - 517. [Full Text] [PDF] |
||||
![]() |
T. Ohkubo, M. Kikuya, H. Metoki, K. Asayama, T. Obara, J. Hashimoto, K. Totsune, H. Hoshi, H. Satoh, and Y. Imai Prognosis of "Masked" Hypertension and "White-Coat" Hypertension Detected by 24-h Ambulatory Blood Pressure Monitoring: 10-Year Follow-Up From the Ohasama Study J. Am. Coll. Cardiol., August 2, 2005; 46(3): 508 - 515. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Jochmann, K. Stangl, E. Garbe, G. Baumann, and V. Stangl Female-specific aspects in the pharmacotherapy of chronic cardiovascular diseases Eur. Heart J., August 2, 2005; 26(16): 1585 - 1595. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Ugajin, A. Hozawa, T. Ohkubo, K. Asayama, M. Kikuya, T. Obara, H. Metoki, H. Hoshi, J. Hashimoto, K. Totsune, et al. White-Coat Hypertension as a Risk Factor for the Development of Home Hypertension: The Ohasama Study Arch Intern Med, July 11, 2005; 165(13): 1541 - 1546. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. G. Pickering, J. E. Hall, L. J. Appel, B. E. Falkner, J. Graves, M. N. Hill, D. W. Jones, T. Kurtz, S. G. Sheps, and E. J. Roccella Recommendations for Blood Pressure Measurement in Humans and Experimental Animals: Part 1: Blood Pressure Measurement in Humans: A Statement for Professionals From the Subcommittee of Professional and Public Education of the American Heart Association Council on High Blood Pressure Research Circulation, February 8, 2005; 111(5): 697 - 716. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Verdecchia, G. P. Reboldi, F. Angeli, G. Schillaci, J. E. Schwartz, T. G. Pickering, Y. Imai, T. Ohkubo, and K. Kario Short- and Long-Term Incidence of Stroke in White-Coat Hypertension Hypertension, February 1, 2005; 45(2): 203 - 208. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. G. Pickering, J. E. Hall, L. J. Appel, B. E. Falkner, J. Graves, M. N. Hill, D. W. Jones, T. Kurtz, S. G. Sheps, and E. J. Roccella Recommendations for Blood Pressure Measurement in Humans and Experimental Animals: Part 1: Blood Pressure Measurement in Humans: A Statement for Professionals From the Subcommittee of Professional and Public Education of the American Heart Association Council on High Blood Pressure Research Hypertension, January 1, 2005; 45(1): 142 - 161. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. H. Fagard, J. A. Staessen, L. Thijs, H. Celis, W. H. Birkenhager, C. J. Bulpitt, P. W. de Leeuw, G. Leonetti, C. Sarti, J. Tuomilehto, et al. Prognostic Significance of Electrocardiographic Voltages and Their Serial Changes in Elderly With Systolic Hypertension Hypertension, October 1, 2004; 44(4): 459 - 464. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Palatini, M. Winnicki, M. Santonastaso, L. Mos, D. Longo, V. Zaetta, M. D. Follo, T. Biasion, and A. C. Pessina Prevalence and Clinical Significance of Isolated Ambulatory Hypertension in Young Subjects Screened for Stage 1 Hypertension Hypertension, August 1, 2004; 44(2): 170 - 174. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. C. Textor, S. J. Taler, T. S. Larson, M. Prieto, M. Griffin, J. Gloor, S. Nyberg, J. Velosa, T. Schwab, and M. Stegall Blood Pressure Evaluation among Older Living Kidney Donors J. Am. Soc. Nephrol., August 1, 2003; 14(8): 2159 - 2167. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. O'Brien Ambulatory blood pressure monitoring in the management of hypertension Heart, May 1, 2003; 89(5): 571 - 576. [Full Text] [PDF] |
||||
![]() |
J. F Inciardi, K. McMahon, and B. L Sauer Factors Associated with Uncontrolled Hypertension in an Affluent, Elderly Population Ann. Pharmacother., April 1, 2003; 37(4): 485 - 489. [Abstract] [Full Text] [PDF] |
||||
![]() |
J Amar, B Chamontin, J Ferrieres, N Danchin, O Grenier, C Cantet, and J-P Cambou Hypertension control at hospital discharge after acute coronary event: influence on cardiovascular prognosis--the PREVENIR study Heart, December 1, 2002; 88(6): 587 - 591. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Pini, M. C. Cavallini, F. Bencini, G. Silvestrini, E. Tonon, W. De Alfieri, N. Marchionni, M. Di Bari, R. B. Devereux, G. Masotti, et al. Cardiovascular remodeling is greater in isolated systolic hypertension than in diastolic hypertension in older adults: the Insufficienza Cardiaca negli Anziani Residenti (ICARE) a Dicomano Study J. Am. Coll. Cardiol., October 2, 2002; 40(7): 1283 - 1289. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. R. Krakoff, T. Pickering, R. Phillips, A. M. Grandi, A. Venco, and M. Moser ABPM Is Valuable for the Management of Hypertension Arch Intern Med, July 8, 2002; 162(13): 1528 - 1530. [Full Text] [PDF] |
||||
![]() |
B. M. Kissela, L. Sauerbeck, D. Woo, J. Khoury, J. Carrozzella, A. Pancioli, E. Jauch, C. J. Moomaw, R. Shukla, J. Gebel, et al. Subarachnoid Hemorrhage: A Preventable Disease With a Heritable Component Stroke, May 1, 2002; 33(5): 1321 - 1326. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Pini, M. C. Cavallini, F. Bencini, L. Stagliano, E. Tonon, F. Innocenti, G. Baldereschi, N. Marchionni, M. Di Bari, R. B. Devereux, et al. Cardiac and Vascular Remodeling in Older Adults With Borderline Isolated Systolic Hypertension: The ICARe Dicomano Study Hypertension, December 1, 2001; 38(6): 1372 - 1376. [Abstract] [Full Text] [PDF] |
||||
![]() |
B.M. Buckley Healthy ageing: ageing safely Eur. Heart J. Suppl., November 1, 2001; 3(suppl_N): N6 - N10. [Abstract] [PDF] |
||||
![]() |
K. Kario, K. Shimada, J. E. Schwartz, T. Matsuo, S. Hoshide, and T. G. Pickering Silent and clinically overt stroke in older Japanese subjects with white-coat and sustained hypertension J. Am. Coll. Cardiol., July 1, 2001; 38(1): 238 - 245. [Abstract] [Full Text] [PDF] |
||||
![]() |
Which Older Patients with Systolic Hypertension Benefit from Treatment? Journal Watch Cardiology, October 13, 2000; 2000(1013): 12 - 12. [Full Text] |
||||
![]() |
Which Older Patients with Systolic Hypertension Benefit from Treatment? Journal Watch (General), September 29, 2000; 2000(929): 1 - 1. [Full Text] |
||||
![]() |
N. M. Kaplan New Issues in the Treatment of Isolated Systolic Hypertension Circulation, September 5, 2000; 102(10): 1079 - 1081. [Full Text] [PDF] |
||||
![]() |
D. Skudicky, P. Sareli, E. Libhaber, G. Candy, I. Radevski, Z. Valtchanova, E. Tshele, L. Thijs, J.-G. Wang, and J. A. Staessen Relationship Between Treatment-Induced Changes in Left Ventricular Mass and Blood Pressure in Black African Hypertensive Patients: Results of the Baragwanath Trial Circulation, February 19, 2002; 105(7): 830 - 836. [Abstract] [Full Text] [PDF] |
||||
|
Circulation Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2000 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |